Patents Assigned to SPIRULINA BIO-LAB CO., LTD.
  • Oral dosage composition
    Patent number: 9132157
    Abstract: The present invention is an oral dosage composition for prevention and treatment of hepatic inflammation such as NASH. The present invention is an oral dosage composition for prevention or treatment of hepatic inflammation, contains the radical scavenging active spirulina powder effective in preventing, ameliorating, and curing NASH or the like.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: September 15, 2015
    Assignee: SPIRULINA BIO-LAB CO., LTD.
    Inventors: Yasumasa Kodo, Hiroshi Nishigaki
  • ORAL DOSAGE COMPOSITION
    Publication number: 20130236421
    Abstract: The present invention is an oral dosage composition for prevention and treatment of hepatic inflammation such as NASH. The present invention is an oral dosage composition for prevention or treatment of hepatic inflammation, contains the radical scavenging active spirulina powder effective in preventing, ameliorating, and curing NASH or the like.
    Type: Application
    Filed: March 18, 2013
    Publication date: September 12, 2013
    Applicant: SPIRULINA BIO-LAB CO., LTD.
    Inventors: Yasumasa Kodo, Hiroshi Nishigaki